Understanding the epidemiology of COVID-19
COVID-19 caused by SARS-CoV-2 was reported in December, 2019 in Wuhan city of Hubei province, China, in people who had visited seafood market. Its symptoms were similar to pneumonia but its infectivity was very high. The main modes of transmission of SARS-CoV-2 were identified as spread by nasal droplets and oral-fecal route and COVID-19 was found to be infectious in incubation and asymptomatic period. Hence, by the time real potential of its pathogenicity was realized, it had spread to many regions of China, other Asian countries, European countries, United States etc. and by April 20, 2020, it had spread to 185 countries all over the world. By this time, China had contained the virus, due to strict social distancing measures, and there was decline in the number of positive cases but in many other countries, especially U.S. and European countries, the cases continued to rise. United States showed the sharpest rise in COVID-19 cases in April, 2020 and also reported the highest number of deaths from the disease. As most of the countries are facing first-wave of COVID-19 by April, 2020, there are fears of second-wave of COVID-19 as China plans to relax social distancing norms to resume business, other work etc. to combat economic losses.
2. Paules CI, Marston HD, Fauci AS. Coronavirus infections - more than just common cold. JAMA. 2020; 323(8): 707-708.
3. World Health Organization. Severe Acute Respiratory Syndrome (SARS). 2020. https://www.who.int/ith/diseases/sars/en/ (Accessed on March 24, 2020).
4. Fehr A, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol Biol. 2015; 1282: 1-23.
5. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382: 1199-1207.
6. Adhikari SP, Meng S, Wu-Y-J, Mao Y-P, Ye R-X, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9: 29.
7. Ki M, Task-force for 2019-nCoV. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020; 42: e2020007.
8. Patel A, Jernigan DB, 2019-nCoV-CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(5): 140-146.
9. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. World Health Organization: Geneva; 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
10. Johns Hopkins University. COVID-19 dashboard by CSSE. 2020. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (Accessed on April 19, 2020)
11. Zhang S, Diao MY, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data driven analysis. Int J Infect Dis. 2020; 93: P201-204.
12. Mackenzie JS, Smith DW. COVID-19: A novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol Aust. 2020; MA20013.
13. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733.
14. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: descriptive study. Lancet. 2020; 395(10223): P507-P513.
15. Jallion S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019; 56: 308-321.
16. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016; 49: 129-133.
17. Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, et al. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clin Microbiol Infect. 2015; 21 (Suppl 2): S27-S32.
18. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): P497-506.
19. Xu X-W, Wu X-X, Jiang X-G, Xu K-J, Ying L-J, Ma C-L, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective cases series. BMJ. 2020; 368: m606.
20. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224): 565-574.
21. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020; 17(5): 1729.
22. Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 323(11): 1092-1093.
23. World Health Organization. Novel coronavirus (2019-nCoV). Situation report 15. 2020; https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200204-sitrep-15-ncov.pdf?sfvrsn=88fe8ad6_2
24. Chinese Center for Disease Control and Prevention, Beijing, China (Feb 17, 2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases in (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2): 145-151.
25. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223): P514-P523.
26. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person to person transmission during incubation period. J Infect Dis. 2020; pii: jiaa077.
27. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382: 970-971.
28. Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020; 16(10): 1678-1685.
29. Zhou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et el. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020; 382: 1177-1179.
30. Cheng PK, Wong DA, Tong LK, Ip SM, Lo AC, Lau CS, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 2004; 363: 1699-1700.
31. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018; 18: e217-227.
32. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-1069.
33. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-1720.
34. Lescure F-X, Bouadma L, Nguyen D, Parisey M, Wickey P-H, Behillil S, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet. 2020; pii: S1473-3099(20)30200-0.
35. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020; 25: doi: 10.2807/1560-7917.
36. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med. 2020; DOI: 10.7326/M20-0504.
37. Nguyen T, Bang DD, Wolff A. 2019 novel coronavirus disease (COVID-19): Paving the road for rapid detection and point-of-care diagnostics. Micromachines. 2020; 11: 306.
38. Park SE. Epidemiology, virology and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Diease-19). Clin Exp Pediatr. 2020; 63(4): 119-124.
39. Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020; 25(9): 2000178.
40. Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen H-L, Chan MCW, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020; DOI: 10.1016/S2666-5247(20)30003-3.
41. Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modeling impact assessment. Lancet. 2020; 395(10233): P1382-1393.
42. Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020; 25(3): 2000044.
43. Phan LT, Nguyen T, Luong Q, Nguyen TV, Nguyen HT, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; 382: 872-874.
44. Pongpirul WA, Pongpirul K, Ratnarathon AC. Journey of a Thai taxi driver and novel coronavirus. N Engl J Med. 2020; 382: 1067-1068.
45. Liu YC, Lio CH, Chang CF, Chou CC, Lin YR. A locally transmitted case of SARS-CoV-2 infection in Taiwan. N Engl J Med. 2020; 382: 1070-1072.
46. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395(10231): P1225-P1228.
47. Day M. Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020; 368: m1165.
48. European Center for Disease Prevention and Control. Situation update for the EU/EEA and the UK, as of 18 April, 2020. 2020; https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea (Accessed on April 19, 2020).
49. Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt F, Holshue M, et al. Active monitoring of persons exposed to patients with confimed COVID-19- United States, January-February, 2020. Weekly. 2020; 69(9): 245-246.
50. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382: 929-936.
51. Bajema K, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, et al. Persons evaluate for 2019 novel coronavirus - United States, January, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(6): 166-170.
52. World Health Organization. Coronavirus Disease 2019 (COVID-19), Situation Report-70. 2020; https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid-19.pdf?sfvrsn=7e0fe3f8_2 (Accessed on April 19, 2020).